June 28, 2018
Presbyterian/St. Luke’s Medical Center (P/SL) is pleased to have performed the 3rd percutaneous (minimally invasive) acetabular reconstruction in the U.S. to treat metastatic bone cancer of the pelvis.
There are approximately 250,000 people in the U.S. with metastatic bone cancer (cancer that has spread to their bones from another originating site). Of these, a significant percentage experience bone pain, weakness and even fractures as a result of cancer weakening the affect bones. Until now patients who experienced a pelvic fracture as a result of metastatic cancer had limited options. A novel, minimally invasion procedure provides an exciting new treatment option for this painful and debilitating condition.
The majority of painful bone metastases are treated with radiation, however when fractures occur, radiation alone is typically insufficient to provide adequate pain relief. In these instances, mechanical stabilization of the fracture is required to relieve pain and improve mobility.
Physicians Dr. Daniel Lerman, an orthopedic oncologist with Sarah Cannon Cancer Institute at P/SL, and Dr. Anthony Brown, an interventional radiologist at P/SL, utilize cutting-edge imaging with three-dimensional computer guidance to facilitate treatment and stabilization of pelvic disease sites that previously required prohibitively extensive and risky operations. Drs. Brown and Lerman develop custom treatment plans for each patient, allowing unique bone screw and cement placement in order to create a rigid internal framework to reinforce the weakened/fractured pelvic bone. This procedure reduces the negative aspects of metastatic bone cancer, by minimizing the pain associated with fracture and allowing patients to regain function. As only small incisions (approximately 1 cm) are required, recovery time is minimized and patients can even be discharged home the same day of receiving treatment.
The care providers in the Sarah Cannon Cancer Institute, work together as a team at Presbyterian/St. Luke’s Medical Center, providing one-of-a-kind solutions to those with metastatic cancer in order to increase patient’s comfort and quality of life.